journal article·2026-02

Peroxynitrite activated near-infrared fluorescent probe for fluorescence and afterglow imaging of Alzheimer's disease brain

Xuefeng Ding, Yiwei Shi, Zixuan Liu, Chengmei Liu, Qian Zhang, Peng Zhang, Caifeng Ding

Dyes and Pigments· Volume 245
Publisher page

Abstract

Peroxynitrite anion (ONOO - ) is a crucial reactive species in pathological and physiological processes, and the elevated levels of ONOO - is concerned with various diseases mechanism. Researches demonstrated its significant contribution to the development of Alzheimer’s disease (AD). In order to elucidate the role of ONOO - in the evolution of AD, herein an activated fluorescent probe A-Hcy-Br was designed initiated the reaction with probe A-Hcy-Br using ONOO - . The probe has extraordinary specificity, sensitivity, and a rapid responsiveness for ONOO - . In addition, due to the excellent mitochondrial targeting ability of probe A-Hcy-Br, it enables effective monitor of brain cells during ONOO - oxidative stress in nerve cells. It is worth noting that A-Hcy-Br displayed well-behaved near-infrared emission and blood-brain barrier (BBB) permeability, encouraging ONOO - expression imaging in the brain. Moreover, the excellent afterglow imaging ability of A-Hcy-Br was successfully used for afterglow imaging in AD mice brain. A-Hcy-Br is further applicable for real-time fluorescence/afterglow monitoring of the therapeutic effect of the AD treatment drug donepezil hydrochloride, providing visual guidance for AD’s drug therapy.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Molecular Sensors and Ion Detection · Sulfur Compounds in Biology · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (47)

Show source-provided references
1. Oxidative stress in drug-induced liver injury (DILI): from mechanisms to biomarkers for use in clinical practice10.3390/antiox10030390 ↗
2. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics10.1038/nrd2222 ↗
3. Quasi-LD-targeted and ONOO- responsive fluorescent probe for investigating the interaction of nonalcoholic fatty liver with drug-induced liver injury10.1021/acs.analchem.2c05674 ↗
4. A highly sensitive and selective near-infrared fluorescent probe for imaging peroxynitrite in living cells and drug-induced liver injury mice10.1021/acs.analchem.3c00007 ↗
5. Research progress of multi-functional fluorescent probes for Alzheimer's disease monitoring10.1016/j.dyepig.2021.109466 ↗
6. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta10.1016/j.neuron.2013.04.014 ↗
7. High performance plasma amyloid-β biomarkers for Alzheimer's disease10.1038/nature25456 ↗
8. Selective visualization of the endogenous peroxynitrite in an inflamed mouse model by a mitochondria-targetable two-photon ratiometric fluorescent probe10.1021/jacs.6b10508 ↗
9. A rationally designed rhodamine-based fluorescent probe for molecular imaging of peroxynitrite in live cells and tissues10.1039/C6SC00012F ↗
10. Dual-channel fluorescent probe for the simultaneous monitoring of peroxynitrite and adenosine-5’-triphosphate in cellular applications10.1021/jacs.1c07954 ↗
11. Frontiers in probing Alzheimer's disease biomarkers with fluorescent small molecules10.1021/acscentsci.8b00951 ↗
12. Physicochemical-property guided design of a highly sensitive probe to image nitrosative stress in the pathology of stroke10.1039/C9SC03798E ↗
13. Screening anti-parkinson’s disease drugs in living mouse brains via a peroxynitrite-activated fluorescent probe10.1021/cbmi.4c00076 ↗
14. An activatable near-infrared afterglow theranostic prodrug with self-sustainable magnification effect of immunogenic cell death10.1002/anie.202209793 ↗
15. Achieving stimuli-responsive amorphous organic afterglow in single-component copolymer through self-doping10.1021/jacs.2c13632 ↗
16. Enhanced blue afterglow through molecular fusion for bio‐applications10.1002/anie.202201630 ↗
17. Nano-particles with ultrasound-induced afterglow luminescence for tumour-specific theranostics10.1038/s41551-022-00978-z ↗
18. H2S-activatable near-infrared afterglow luminescent probes for sensitive molecular imaging in vivo10.1038/s41467-020-14307-y ↗
19. An organic afterglow protheranostic nanoassembly
20. Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases10.1002/adma.201801362 ↗
21. Peroxynitrite responsive second near-infrared cyanine dye J-Aggregate for drug-induced hepatotoxicity monitoring10.1021/cbmi.4c00111 ↗
22. An activity-based fluorescent probe for imaging fluctuations of peroxynitrite (ONOO-) in the Alzheimer's Disease brain
23. Lysosome-specific sensing and imaging of pH variations in vitro and in vivo utilizing a near-infrared boron complex10.1039/C8TB03353F ↗
24. Novel farvisible and near-infrared pH probes based on styrylcyanine for imaging intracellular pH in live cells10.1039/c2cc35363f ↗
25. Novel near infrared fluorescent pH sensors based on 1-aminoperylene bisimides covalently grafted onto poly(acryloylmorpholine)10.1039/c3cc39151e ↗
26. A unique approach to development of near-infrared fluorescent sensors for in vivo imaging10.1021/ja305802v ↗
27. A phosphinate-based near-infrared fluorescence probe for imaging the superoxide radical anion in in vitro and in vivo10.1039/C5CC09976E ↗
28. Mitochondria-targeted near-infrared fluorescent Off-On probe for selective detection of cysteine in living cells and in vivo10.1021/acsami.5b10607 ↗
29. Ratiometric near-infrared fluorescent probes based on through-bond energy transfer and π-conjugation modulation between tetraphenylethene and hemicyanine moieties for sensitive detection of pH changes in live cells10.1021/acs.bioconjchem.8b00111 ↗
30. A unique class of near-infrared functional fluorescent dyes with carboxylic-acid-modulated fluorescence ON/OFF switching: rational design, synthesis, optical properties, theoretical calculations, and applications for fluorescence imaging in living animals10.1021/ja209292b ↗
31. Hemicyanine-based high resolution ratiometric near-Infrared fluorescent probe for monitoring pH changes in vivo10.1021/ac5045498 ↗
32. New near-infrared fluorescence imaging platform with large stokes shift for carboxylesterase 2 detection in thyroid cancer and inflammatory diseases diagnosis10.1021/acs.analchem.3c04399 ↗
33. Increased Iron and free radical generation in preclinical alzheimer disease and mild cognitive impairment10.3233/JAD-2010-1239 ↗
34. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease
35. A near-IR ratiometric fluorescent probe for the precise tracking of senescence: a multidimensional sensing assay of biomarkers in cell senescence pathways10.1039/D4SC00595C ↗
36. Near-infrared mito-specific fluorescent probe for ratiometric detection and imaging of alkaline phosphatase activity with high sensitivity10.1039/C8TB02799D ↗
37. “Four-In-One” design of a hemicyanine-based modular scaffold for high-contrast activatable molecular afterglow imaging10.1021/jacs.2c11466 ↗
38. The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease10.1016/j.biopha.2023.114223 ↗
39. Alzheimer's disease: donepezil effects on cholesterol and oxysterol plasma levels10.1002/alz.044144 ↗
40. Subcutaneous implantable microneedle System for the treatment of alzheimer's disease by delivering donepezil10.1021/acs.biomac.2c01155 ↗
41. Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease
42. The efficacy of donepezil administration on acetylcholin-esterase activity and altered redox homeostasis in Alzheimer's disease10.1016/j.biopha.2017.03.101 ↗
43. A drug for Alzheimer's disease, promotes oligodendrocyte genera-tion and remyelination10.1038/s41401-018-0206-4 ↗
44. A novel targeted and high-efficiency nanosystem for combinational therapy for Alzheimer's Disease10.1002/advs.201902906 ↗
45. Alzheimer's disease: experimental models and reality10.1007/s00401-016-1662-x ↗
46. Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer's disease10.1038/s41467-020-18525-2 ↗
47. Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy10.1126/sciadv.abc7031 ↗